Aegerion Pharmaceuticals, Inc. AEGR has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at AEGR
Investors considering a purchase of Aegerion Pharmaceuticals Inc ... or a 11% annualized rate of return (at Stock Options Channel we call this the YieldBoost). Selling a put does not give an investor access to AEGR’s …
In Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Broadfin initiated a stake during the first quarter, initially …
Stake
Aegerion Pharmaceuticals (AEGR): AEGR stock is up 3.7% today ... Article printed from InvestorPlace Media, http://investorplace.com/2014/10/hottest-healthcare-stocks-now-ptct-aegr-bkd-acad-ptct-aegr-bkd-2/.
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here. Aegerion Pharmaceuticals, Inc. …
Ning Yang, Ph.D. and Andrew McDonald, Ph.D. Aegerion's (AEGR) stock has risen roughly 50% since October 11, 2012. We attended the company's investor event in New York on October 23, and it's clear that investors …
Investors eyeing a purchase of Aegerion Pharmaceuticals Inc (Symbol: AEGR) stock, but cautious about paying the going market price of $23.29/share, might benefit from considering selling puts among the alternative …
Stock tumbled 30% in extended trading following this news Aegerion Pharmaceuticals, Inc. (AEGR) released financial and operational results for the third quarter (3Q) of fiscal year 2014 (FY14) after market closed …